StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
285
This month
39
This week
5
This year
195
Today
1
Yesterday
5
Publishing Date
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 22
3
2022 - 06 - 17
6
2022 - 06 - 06
3
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 18
3
2022 - 05 - 17
3
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 04 - 25
3
2022 - 04 - 06
3
2022 - 04 - 01
2
2022 - 03 - 31
3
2022 - 03 - 30
3
2022 - 03 - 25
6
2022 - 03 - 23
3
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 16
3
2022 - 03 - 14
3
2022 - 03 - 10
2
2022 - 03 - 08
3
2022 - 03 - 07
2
2022 - 03 - 04
4
2022 - 03 - 03
2
2022 - 03 - 01
4
2022 - 02 - 28
3
2022 - 02 - 25
2
2022 - 02 - 23
2
2022 - 02 - 18
2
2022 - 02 - 09
2
2022 - 02 - 01
2
2022 - 01 - 21
2
2022 - 01 - 19
2
2021 - 12 - 22
6
2021 - 12 - 20
4
2021 - 12 - 16
3
2021 - 12 - 14
3
2021 - 12 - 11
2
2021 - 12 - 06
2
2021 - 11 - 24
2
2021 - 11 - 12
3
2021 - 11 - 10
2
2021 - 11 - 04
3
2021 - 11 - 02
3
2021 - 11 - 01
2
2021 - 10 - 29
2
2021 - 10 - 28
4
2021 - 10 - 22
3
2021 - 10 - 21
3
2021 - 10 - 20
4
2021 - 10 - 18
2
2021 - 10 - 13
3
2021 - 10 - 12
2
2021 - 10 - 08
3
2021 - 10 - 07
2
2021 - 10 - 06
2
2021 - 10 - 01
3
Sector
Commercial services
1
Communications
1
Consumer durables
3
Consumer non-durables
1
Distribution services
1
Electronic technology
3
Health services
8
Health technology
285
Manufacturing
35
N/a
4
Process industries
2
Producer manufacturing
3
Professional, scientific, and technical services
3
Retail trade
1
Technology services
5
Tags
Als
6
America
11
Antibody
3
Application
4
Approval
6
Biocanada
4
Biosimilar
6
Breast cancer
4
Cancer
21
Car-t
6
Cel
5
Ces
3
Chmp
5
Collaboration
4
Device
6
Diabetes
6
Diabetic
4
Diagnostic
5
Diagnostics
3
Disease
20
Drug
43
Drug delivery
4
Earnings
7
Ema
6
Europe
9
Expected
3
Eye
4
Fda
10
Fda approval
4
Fda-approvals
3
Financial results
5
For
20
Growing
6
Growth
57
Health
6
Heart
3
Immunotherapy
7
Kymriah
5
Leukemia
7
Liver
8
Macular
4
Market
73
Myeloid leukemia
5
N/a
246
Novartis
45
Order
4
People
7
Pharma
4
Positive
7
Potential
4
Report
38
Research
30
Results
13
Sales
4
Sclerosis
5
T-cell
6
Therapeutics
19
Therapy
22
Treatment
35
Trial
4
Entities
3m company
3
Abbott laboratories
23
Abbvie inc.
45
Acadia pharmaceuticals inc.
2
Adaptimmune therapeutics plc
3
Akorn inc
2
Alkermes plc
2
Alnylam pharmaceuticals, inc.
2
Amgen inc.
35
Antares pharma, inc.
2
Arrival
3
Astellas pharma inc
22
Astrazeneca plc
48
Bausch health companies inc.
19
Baxter international inc.
10
Becton, dickinson and company
9
Beigene, ltd.
6
Biogen inc.
9
Bluebird bio, inc.
2
Boston scientific corporation
8
Brainstorm cell therapeutics inc.
2
Bristol-myers squibb company
25
Cellectis s.a.
2
Cryolife, inc.
2
Cti biopharma corp.
2
Eli lilly and company
28
Endo international plc
4
Fresenius medical care ag & co. kgaa
2
General electric company
3
Genmab a/s
4
Gilead sciences, inc.
3
Glaxosmithkline plc
72
Incyte corporation
7
Integra lifesciences holdings corporation
2
Jazz pharmaceuticals plc
4
Johnson & johnson
49
Koninklijke philips n.v.
4
Laboratory corporation of america holdings
2
Luminex corporation
2
Mallinckrodt plc
3
Medtronic plc
14
Mesoblast limited
2
Mesoblast ltd
2
Morphosys ag
3
Mylan n.v.
10
Nikon corp
3
Novartis ag
285
Novo nordisk a/s
5
Pfizer, inc.
16
Qiagen n.v.
3
Regenxbio inc.
4
Sanofi
62
Smith & nephew plc
5
Stryker corporation
6
Takeda pharmaceutical company limited
13
Teva pharmaceutical industries ltd
51
Thermo fisher scientific inc
13
Uniqure n.v.
3
Viatris inc.
20
Xencor, inc.
3
Symbols
AAPL
481
ABB
606
ABBV
480
ABLZF
347
ABT
682
AMGN
342
APO
270
ARVL
1728
AZN
298
BDX
400
BMY
354
BNPQF
544
BNPQY
544
BNPZY
543
BSX
293
CNY
434
CSCO
428
DHR
339
DOW
287
ERIC
721
EXTR
320
F
267
FNCTF
2047
FRBA
314
GE
454
GOOG
324
GOOGL
327
GSK
407
HON
727
HUBS
997
IBM
330
INR
437
INTC
408
JNJ
2194
LLY
862
LYV
309
MDT
588
MLPY
435
MMM
448
MS
2098
MSFT
596
NOK
280
NVO
295
NVS
487
NVSEF
285
OCX
269
ORCL
552
PFE
372
PHG
457
PPRUF
376
PPRUY
377
SAP
662
SAPGF
397
SNOW
337
SNY
1873
SNYNF
923
TMO
629
TOT
718
URR
433
VZ
444
Exchanges
Amex
2
Nasdaq
285
Nyse
285
Crawled Date
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 17
6
2022 - 06 - 06
3
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 18
3
2022 - 05 - 17
3
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 04 - 25
3
2022 - 04 - 07
2
2022 - 04 - 06
3
2022 - 04 - 05
2
2022 - 04 - 01
2
2022 - 03 - 31
3
2022 - 03 - 30
3
2022 - 03 - 25
6
2022 - 03 - 23
3
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 16
3
2022 - 03 - 14
4
2022 - 03 - 10
2
2022 - 03 - 08
3
2022 - 03 - 07
2
2022 - 03 - 04
4
2022 - 03 - 03
2
2022 - 03 - 01
3
2022 - 02 - 28
3
2022 - 02 - 25
2
2022 - 02 - 23
2
2022 - 02 - 18
2
2022 - 02 - 09
2
2022 - 02 - 01
2
2022 - 01 - 21
2
2022 - 01 - 19
2
2021 - 12 - 22
5
2021 - 12 - 20
4
2021 - 12 - 16
3
2021 - 12 - 14
3
2021 - 12 - 06
2
2021 - 11 - 24
2
2021 - 11 - 12
3
2021 - 11 - 10
2
2021 - 11 - 04
3
2021 - 11 - 02
3
2021 - 11 - 01
2
2021 - 10 - 29
2
2021 - 10 - 28
4
2021 - 10 - 22
2
2021 - 10 - 21
3
2021 - 10 - 20
4
2021 - 10 - 18
2
2021 - 10 - 13
3
2021 - 10 - 12
2
2021 - 10 - 08
3
2021 - 10 - 07
2
2021 - 10 - 06
2
2021 - 10 - 01
3
Crawled Time
00:00
3
00:20
2
01:00
8
02:00
4
03:00
8
04:00
4
04:20
2
05:00
4
06:00
9
07:00
12
08:00
8
09:00
8
10:00
8
11:00
13
12:00
24
12:20
6
12:30
8
13:00
6
13:15
2
13:20
3
13:30
4
14:00
15
14:15
1
14:20
2
14:30
2
15:00
10
15:15
1
15:20
3
15:30
4
16:00
19
16:20
1
17:00
19
18:00
14
19:00
12
20:00
8
20:20
1
21:00
10
22:00
10
23:00
7
Source
investors.biomarin.com
1
ir.voyagertherapeutics.com
1
www.biospace.com
39
www.globenewswire.com
52
www.prnewswire.com
191
www.voyagertherapeutics.com
1
Sort by:
after hours percent change
|
delayed percent change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
NVSEF
save search
Herpes Treatment Market size to grow by USD 723.04 Mn | Market Research Insights highlight increasing prevalence of herpes infection as Key Driver | Technavio
Published:
2022-06-29
(Just crawled : 04:00)
- prnewswire.com
BHC
|
News
A
|
$8.83
1.73%
0.11%
|
|
Health Technology
|
Email alert
Add to watchlist
VTRS
|
News
|
$10.91
-1.44%
-0.72%
|
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$21.99
|
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$8.3
|
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$43.35
-0.8%
0.19%
|
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$84.01
|
|
Health Technology
|
Email alert
Add to watchlist
treatment
research
infection
market
Cancer Immunotherapy Market Expands with Rising Adoption of Target Therapy in Cancer Treatment, States TMR Report
Published:
2022-06-27
(Crawled : 16:00)
- prnewswire.com
AZNCF
|
$127.2501
|
|
Health Technology
|
1.93%
|
O:
-1.55%
H:
4.43%
C:
0.03%
NVS
|
News
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
0.77%
|
O:
1.86%
H:
1.05%
C:
0.24%
LLY
|
News
S
|
$317.62
-2.95%
-0.03%
|
|
Health Technology
|
-0.55%
|
O:
1.32%
H:
0.0%
C:
0.0%
GSK
|
News
|
$43.35
-0.8%
0.19%
|
|
Health Technology
|
-0.78%
|
O:
-0.16%
H:
0.61%
C:
0.18%
GLAXF
|
News
|
$21.99
|
|
Health Technology
|
4.22%
|
O:
0.47%
H:
3.73%
C:
3.73%
PFE
|
News
|
$50.66
-2.35%
0.4%
|
|
Health Technology
|
-0.16%
|
O:
1.46%
H:
1.45%
C:
0.78%
SPPI
A
|
$0.8436
-1.91%
1.74%
|
|
Health Technology
|
-3.43%
|
O:
0.0%
H:
2.28%
C:
-2.27%
SNYNF
|
News
|
$108.84
|
|
Health Technology
|
4.15%
|
O:
4.15%
H:
0.0%
C:
0.0%
BMY
|
$78.7
-1.6%
0.38%
|
|
Health Technology
|
0.1%
|
O:
0.78%
H:
1.72%
C:
0.95%
SNY
|
News
|
$52.13
-0.89%
0.0%
|
|
Health Technology
|
-0.55%
|
O:
0.53%
H:
0.0%
C:
0.0%
AZN
|
$65.94
-0.86%
0.21%
|
|
Health Technology
|
-0.86%
|
O:
-0.36%
H:
1.22%
C:
0.38%
immunotherapy
report
therapy
cancer
market
Cancer Gene Therapy Market to Grow at 10.1% through 2032, Amid High Adoption in Breast Cancer Treatment - Future Market Insights, Inc.
Published:
2022-06-27
(Crawled : 15:20)
- prnewswire.com
CRNX
|
$17.74
-4.57%
0.0%
|
|
Health Technology
|
-9.54%
|
O:
0.66%
H:
1.22%
C:
-5.83%
AZN
|
$65.94
-0.86%
0.21%
|
|
Health Technology
|
-0.86%
|
O:
-0.36%
H:
1.22%
C:
0.38%
ADAP
S
|
$1.74
2.35%
5.88%
|
|
Health Technology
|
7.41%
|
O:
1.85%
H:
6.67%
C:
3.03%
AZNCF
|
$127.2501
|
|
Health Technology
|
1.93%
|
O:
-1.55%
H:
4.43%
C:
0.03%
NVS
|
News
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
0.77%
|
O:
1.86%
H:
1.05%
C:
0.24%
GSK
|
News
|
$43.35
-0.8%
0.19%
|
|
Health Technology
|
-0.78%
|
O:
-0.16%
H:
0.61%
C:
0.18%
GLAXF
|
News
|
$21.99
|
|
Health Technology
|
4.22%
|
O:
0.47%
H:
3.73%
C:
3.73%
AMGN
|
$243.6
-0.51%
0.47%
|
|
Health Technology
|
-0.76%
|
O:
-0.08%
H:
0.45%
C:
-0.13%
treatment
therapy
cancer
market
Valued to be $104.2 Million by 2026, Eye Health Supplements Slated for Robust Growth Worldwide
Published:
2022-06-27
(Crawled : 14:00)
- prnewswire.com
PFE
|
News
|
$50.66
-2.35%
0.4%
|
|
Health Technology
|
-0.16%
|
O:
1.46%
H:
1.45%
C:
0.78%
NVS
|
News
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
0.77%
|
O:
1.86%
H:
1.05%
C:
0.24%
for
health
eye
growth
Valued to be $12.9 Billion by 2026, Crohn`s Disease (CD) Therapy Slated for Robust Growth Worldwide
Published:
2022-06-27
(Crawled : 12:20)
- prnewswire.com
JNJ
|
News
|
$176.94
-2.84%
0.18%
|
|
Health Technology
|
-1.83%
|
O:
0.78%
H:
0.94%
C:
0.26%
NVO
|
News
|
$108.3
-4.07%
2.17%
|
|
Health Technology
|
-3.14%
|
O:
0.72%
H:
0.0%
C:
0.0%
CCXI
|
$25.08
-3.54%
0.0%
|
|
Health Technology
|
-9.39%
|
O:
-4.88%
H:
1.04%
C:
-1.25%
AZN
|
$65.94
-0.86%
0.21%
|
|
Health Technology
|
-0.86%
|
O:
-0.36%
H:
1.22%
C:
0.38%
AZNCF
|
$127.2501
|
|
Health Technology
|
1.93%
|
O:
-1.55%
H:
4.43%
C:
0.03%
NVS
|
News
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
0.77%
|
O:
1.86%
H:
1.05%
C:
0.24%
PFE
|
News
|
$50.66
-2.35%
0.4%
|
|
Health Technology
|
-0.16%
|
O:
1.46%
H:
1.45%
C:
0.78%
disease
for
therapy
growth
Irritable Bowel Syndrome Treatment Market to Surpass US$ 3,902.9 Million by 2030 - Coherent Market Insights
Published:
2022-06-24
(Crawled : 18:00)
- prnewswire.com
ALPMY
|
$15.95
|
|
Manufacturing
|
1.38%
|
O:
4.33%
H:
0.0%
C:
-2.44%
ALPMF
|
$15.83
|
|
Health Technology
|
6.07%
|
O:
0.99%
H:
0.0%
C:
-0.5%
ABBV
|
News
|
$152.49
-0.42%
0.0%
|
|
Health Technology
|
2.75%
|
O:
1.57%
H:
0.0%
C:
0.0%
BHC
|
News
A
|
$8.83
1.73%
0.11%
|
|
Health Technology
|
21.46%
|
O:
5.78%
H:
13.91%
C:
13.78%
IRWD
|
$11.54
-0.52%
0.0%
|
|
Health Technology
|
4.34%
|
O:
0.27%
H:
2.08%
C:
1.99%
TAK
|
$13.86
-1.42%
0.0%
|
|
Health Technology
|
0.95%
|
O:
0.36%
H:
0.0%
C:
0.0%
NVS
|
News
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
3.17%
|
O:
2.38%
H:
0.0%
C:
0.0%
treatment
market
Psoriasis Treatment Market Players Observe Rising Trend of Personalized Medicines, According to TMR Report
Published:
2022-06-24
(Crawled : 12:00)
- prnewswire.com
AZN
|
$65.94
-0.86%
0.21%
|
|
Health Technology
|
3.52%
|
O:
4.41%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$176.94
-2.84%
0.18%
|
|
Health Technology
|
0.07%
|
O:
1.94%
H:
0.0%
C:
0.0%
PFE
|
News
|
$50.66
-2.35%
0.4%
|
|
Health Technology
|
2.8%
|
O:
2.96%
H:
0.0%
C:
0.0%
AZNCF
|
$127.2501
|
|
Health Technology
|
3.95%
|
O:
0.64%
H:
4.18%
C:
1.33%
NVS
|
News
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
3.17%
|
O:
2.38%
H:
0.0%
C:
0.0%
LLY
|
News
S
|
$317.62
-2.95%
-0.03%
|
|
Health Technology
|
2.75%
|
O:
3.32%
H:
0.0%
C:
0.0%
treatment
report
psoriasis
market
Novartis receives positive CHMP opinion for Scemblix®, a novel treatment for adult patients with chronic myeloid leukemia
Published:
2022-06-24
(Crawled : 12:00)
- globenewswire.com
NVS
|
News
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
3.17%
|
O:
2.38%
H:
0.0%
C:
0.0%
scemblix
treatment
for
chmp
novartis
leukemia
positive
Rheumatoid Arthritis Drugs Market Size to Grow by USD 14.90 Billion | 37% of the growth will originate from Europe | Technavio
Published:
2022-06-24
(Crawled : 09:00)
- prnewswire.com
ALPMY
|
$15.95
|
|
Manufacturing
|
1.38%
|
O:
4.33%
H:
0.0%
C:
-2.44%
SNY
|
News
|
$52.13
-0.89%
0.0%
|
|
Health Technology
|
2.92%
|
O:
3.49%
H:
0.0%
C:
0.0%
ALPMF
|
$15.83
|
|
Health Technology
|
6.07%
|
O:
0.99%
H:
0.0%
C:
-0.5%
ABBV
|
News
|
$152.49
-0.42%
0.0%
|
|
Health Technology
|
2.75%
|
O:
1.57%
H:
0.0%
C:
0.0%
GLAXF
|
News
|
$21.99
|
|
Health Technology
|
5.59%
|
O:
3.19%
H:
2.28%
C:
-1.81%
AMGN
|
$243.6
-0.51%
0.47%
|
|
Health Technology
|
0.71%
|
O:
0.92%
H:
0.82%
C:
0.56%
GSK
|
News
|
$43.35
-0.8%
0.19%
|
|
Health Technology
|
1.93%
|
O:
1.79%
H:
0.95%
C:
0.92%
NVS
|
News
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
3.17%
|
O:
2.38%
H:
0.0%
C:
0.0%
GLMD
|
$0.5756
10.69%
0.0%
|
|
Health Technology
|
19.6%
|
O:
1.21%
H:
0.0%
C:
-3.5%
europe
growth
market
Novartis renews commitment to neglected tropical disease and malaria elimination, investing USD 250 million over five years to research and develop new treatments
Published:
2022-06-23
(Crawled : 01:00)
- globenewswire.com
NVS
|
News
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
3.48%
|
O:
0.3%
H:
0.0%
C:
0.0%
research
disease
novartis
Novartis Tafinlar + Mekinist receives FDA approval for first tumor-agnostic indication for BRAF V600E solid tumors
Published:
2022-06-22
(Crawled : 00:00)
- globenewswire.com
NVS
|
News
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
3.48%
|
O:
0.3%
H:
0.0%
C:
0.0%
fda
for
novartis
approval
tafinlar
Global Recombinant Vaccines Market to Surpass US$ 1,809.7 Million by 2030 - Coherent Market Insights
Published:
2022-06-22
(Crawled : 18:00)
- prnewswire.com
JNJ
|
News
|
$176.94
-2.84%
0.18%
|
|
Health Technology
|
4.24%
|
O:
1.36%
H:
0.0%
C:
0.0%
SNY
|
News
|
$52.13
-0.89%
0.0%
|
|
Health Technology
|
4.41%
|
O:
-0.4%
H:
0.0%
C:
0.0%
NVS
|
News
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
1.85%
|
O:
-1.57%
H:
0.0%
C:
0.0%
market
Novartis expands Beacon of Hope through alliances with Historically Black Medical Schools to address systemic health disparities
Published:
2022-06-22
(Crawled : 12:00)
- prnewswire.com
SNY
|
News
|
$52.13
-0.89%
0.0%
|
|
Health Technology
|
4.41%
|
O:
-0.4%
H:
0.0%
C:
0.0%
NVS
|
News
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
1.85%
|
O:
-1.57%
H:
0.0%
C:
0.0%
beacon
novartis
health
Novartis plans to petition the U.S. Court of Appeals for the Federal Circuit for further review to uphold validity of the Gilenya® (fingolimod) dosing regimen patent
Published:
2022-06-21
(Crawled : 20:00)
- globenewswire.com
NVS
|
News
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
1.85%
|
O:
-1.57%
H:
0.0%
C:
0.0%
gilenya
patent
for
novartis
review
Liver Cancer Drugs Market size to grow by USD 5.29 billion | Market Research Insights highlight the increasing incidence of liver cancer as Key Driver | Technavio
Published:
2022-06-21
(Crawled : 03:00)
- prnewswire.com
AZN
|
$65.94
-0.86%
0.21%
|
|
Health Technology
|
7.71%
|
O:
2.03%
H:
0.0%
C:
0.0%
NVS
|
News
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
3.29%
|
O:
1.41%
H:
0.0%
C:
0.0%
research
liver
cancer
market
Global Meningitis Vaccines Market to Surpass US$ 6,669.3 Million by 2030 - Coherent Market Insights
Published:
2022-06-20
(Crawled : 19:00)
- prnewswire.com
NVS
|
News
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
3.29%
|
O:
1.41%
H:
0.0%
C:
0.0%
SNY
|
News
|
$52.13
-0.89%
0.0%
|
|
Health Technology
|
5.87%
|
O:
1.4%
H:
0.0%
C:
0.0%
market
Global Gene Therapy Market Research Report 2022-2031 Featuring Major Players - Novartis AG; Bluebird bio, Inc.; Spark Therapeutics, Inc; Audentes Therapeutics; Voyager Therapeutics
Published:
2022-06-20
(Crawled : 12:00)
- prnewswire.com
SNY
|
News
|
$52.13
-0.89%
0.0%
|
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$108.84
|
|
Health Technology
|
Email alert
Add to watchlist
QURE
|
$18.6
-0.38%
-0.38%
|
|
Health Technology
|
Email alert
Add to watchlist
CLLS
|
News
|
$2.92
-9.03%
0.0%
|
|
Health Technology
|
Email alert
Add to watchlist
SRPT
|
$74.59
-2.24%
-0.13%
|
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$84.01
|
|
Health Technology
|
Email alert
Add to watchlist
AGTC
|
$0.75
2.04%
0.54%
|
|
Health Technology
|
Email alert
Add to watchlist
BLUE
A
|
$4.035
-5.94%
-0.7%
|
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
Email alert
Add to watchlist
research
report
novartis
therapeutics
therapy
market
Global Tacrolimus Market to Surpass US$ 9,380.2 Million by 2030 - Coherent Market Insights
Published:
2022-06-17
(Crawled : 19:00)
- prnewswire.com
NVS
|
News
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$84.01
|
|
Health Technology
|
Email alert
Add to watchlist
ALPMF
|
$15.83
|
|
Health Technology
|
Email alert
Add to watchlist
MYL
|
$15.86
0%
|
|
Health Technology
|
Email alert
Add to watchlist
TFFP
|
$5.81
-3.65%
4.98%
|
|
Health Technology
|
Email alert
Add to watchlist
ALPMY
|
$15.95
|
|
Manufacturing
|
Email alert
Add to watchlist
tacrolimus
market
Biologic Therapy Market Information: By Product and Geography - Global Forecast till 2025
Published:
2022-06-17
(Crawled : 14:00)
- prnewswire.com
AZNCF
|
$127.2501
|
|
Health Technology
|
10.91%
|
O:
1.89%
H:
0.0%
C:
-0.64%
NVS
|
News
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
3.36%
|
O:
0.07%
H:
0.0%
C:
0.0%
GSK
|
News
|
$43.35
-0.8%
0.19%
|
|
Health Technology
|
4.48%
|
O:
-0.24%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$84.01
|
|
Health Technology
|
4.91%
|
O:
0.74%
H:
0.52%
C:
-3.23%
GLAXF
|
News
|
$21.99
|
|
Health Technology
|
6.81%
|
O:
0.01%
H:
0.17%
C:
0.17%
ABBV
|
News
|
$152.49
-0.42%
0.0%
|
|
Health Technology
|
11.76%
|
O:
1.05%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$108.84
|
|
Health Technology
|
12.02%
|
O:
-1.76%
H:
5.75%
C:
5.5%
JNJ
|
News
|
$176.94
-2.84%
0.18%
|
|
Health Technology
|
5.13%
|
O:
1.35%
H:
0.0%
C:
0.0%
SNY
|
News
|
$52.13
-0.89%
0.0%
|
|
Health Technology
|
7.34%
|
O:
1.39%
H:
0.0%
C:
0.0%
AZN
|
$65.94
-0.86%
0.21%
|
|
Health Technology
|
8.35%
|
O:
0.59%
H:
0.0%
C:
0.0%
therapy
market
Global Conjugated Monoclonal Antibodies (mAbs) Market Report 2022: A $12.09 Billion Market by 2026 - Forecast to 2031
Published:
2022-06-17
(Crawled : 13:20)
- prnewswire.com
ABBV
|
News
|
$152.49
-0.42%
0.0%
|
|
Health Technology
|
11.76%
|
O:
1.05%
H:
0.0%
C:
0.0%
NVS
|
News
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
3.36%
|
O:
0.07%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$84.01
|
|
Health Technology
|
4.91%
|
O:
0.74%
H:
0.52%
C:
-3.23%
report
market
← Previous
1
2
3
4
5
6
7
8
9
…
14
15
Next →
Your saved searches
Save your searches and get alerts when important news are released.
Mentioned Today
ACN
|
News
|
$283.8
-3.01%
0.07%
|
|
Technology Services
ARVL
|
News
|
$1.605
-5.03%
-0.59%
|
|
Manufacturing
BHC
|
News
4
|
$8.83
1.73%
0.11%
|
|
Health Technology
BTG
|
News
|
$3.56
-2.73%
0.84%
|
|
Non-Energy Minerals
CGNT
|
News
|
$4.56
-28.97%
4.05%
|
|
DELL
|
News
|
$48.94
-2.59%
0.0%
|
|
Electronic Technology
DKILF
|
News
|
$166.37
|
|
Producer Manufacturing
DKILY
|
News
|
$16.05
|
|
Manufacturing
GBERF
|
News
|
$546.0
|
|
Producer Manufacturing
GBERY
|
News
|
$49.49
|
|
Manufacturing
GLAXF
|
News
|
$21.99
|
|
Health Technology
GLPI
|
News
0 d
|
$46.68
-0.09%
0.0%
|
|
Finance
GSK
|
News
|
$43.35
-0.8%
0.19%
|
|
Health Technology
INCY
|
News
|
$75.64
-2.22%
0.93%
|
|
Health Technology
INTU
|
News
4
|
$386.39
-4.53%
0.31%
|
|
Technology Services
IRCP
|
News
|
$2.4984
0.06%
|
|
Finance
JCI
|
News
|
$48.44
-0.43%
0.0%
|
|
Producer Manufacturing
JTEKF
|
News
|
$
0%
|
|
Producer Manufacturing
JTEKY
|
News
|
$24.29
|
|
Manufacturing
LEA
|
News
|
$134.75
0.57%
0.0%
|
|
Producer Manufacturing
LLY
|
News
4
|
$317.62
-2.95%
-0.03%
|
|
Health Technology
NDAQ
|
News
4
|
$154.64
-2.08%
-0.23%
|
|
Finance
NUVB
|
News
|
$3.55
-2.47%
0.0%
|
|
NVS
|
News
|
$84.17
-1.3%
0.17%
|
|
Health Technology
NVSEF
|
News
|
$84.01
|
|
Health Technology
PCRFF
|
News
|
$8.15
|
|
n/a
PCRFY
|
News
|
$8.22
|
|
n/a
PPRUF
|
News
|
$534.0
|
|
Consumer Non-Durables
PPRUY
|
News
|
$52.24
|
|
Manufacturing
TEVJF
|
News
|
$8.3
|
|
Health Technology
TMO
|
News
|
$535.77
-1.45%
-0.09%
|
|
Health Technology
UL
|
News
|
$45.33
-1.46%
-0.73%
|
|
Consumer Non-Durables
UNLYF
|
News
|
$47.2225
|
|
Consumer Non-Durables
VTRS
|
News
|
$10.91
-1.44%
-0.72%
|
|
Health Technology
WFC
|
News
4
|
$40.18
-0.15%
0.15%
|
|
Finance
ZTS
|
News
4
|
$170.12
-2.01%
0.96%
|
|
Health Technology